These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical Assessment, Genetics, and Treatment Approaches in Autism Spectrum Disorder (ASD). Genovese A; Butler MG Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630718 [TBL] [Abstract][Full Text] [Related]
3. Functional DNA methylation signatures for autism spectrum disorder genomic risk loci: 16p11.2 deletions and CHD8 variants. Siu MT; Butcher DT; Turinsky AL; Cytrynbaum C; Stavropoulos DJ; Walker S; Caluseriu O; Carter M; Lou Y; Nicolson R; Georgiades S; Szatmari P; Anagnostou E; Scherer SW; Choufani S; Brudno M; Weksberg R Clin Epigenetics; 2019 Jul; 11(1):103. PubMed ID: 31311581 [TBL] [Abstract][Full Text] [Related]
4. The genetics of autism. Muhle R; Trentacoste SV; Rapin I Pediatrics; 2004 May; 113(5):e472-86. PubMed ID: 15121991 [TBL] [Abstract][Full Text] [Related]
5. Prospective study of autism phenomenology and the behavioural phenotype of Phelan-McDermid syndrome: comparison to fragile X syndrome, Down syndrome and idiopathic autism spectrum disorder. Richards C; Powis L; Moss J; Stinton C; Nelson L; Oliver C J Neurodev Disord; 2017 Nov; 9(1):37. PubMed ID: 29126394 [TBL] [Abstract][Full Text] [Related]
6. Dysregulation of mTOR signaling mediates common neurite and migration defects in both idiopathic and 16p11.2 deletion autism neural precursor cells. Prem S; Dev B; Peng C; Mehta M; Alibutud R; Connacher RJ; St Thomas M; Zhou X; Matteson P; Xing J; Millonig JH; DiCicco-Bloom E Elife; 2024 Mar; 13():. PubMed ID: 38525876 [TBL] [Abstract][Full Text] [Related]
9. Assessment and treatment in autism spectrum disorders: a focus on genetics and psychiatry. Butler MG; Youngs EL; Roberts JL; Hellings JA Autism Res Treat; 2012; 2012():242537. PubMed ID: 22934170 [TBL] [Abstract][Full Text] [Related]
17. Psychometric Study of the Social Responsiveness Scale in Phelan-McDermid Syndrome. Gergoudis K; Weinberg A; Templin J; Farmer C; Durkin A; Weissman J; Siper P; Foss-Feig J; Del Pilar Trelles M; Bernstein JA; Buxbaum JD; Berry-Kravis E; Powell CM; Sahin M; Soorya L; Thurm A; Kolevzon A; Autism Res; 2020 Aug; 13(8):1383-1396. PubMed ID: 32406614 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of two Shank3 and the Cacna1c mouse models of autism spectrum disorder. Kabitzke PA; Brunner D; He D; Fazio PA; Cox K; Sutphen J; Thiede L; Sabath E; Hanania T; Alexandrov V; Rasmusson R; Spooren W; Ghosh A; Feliciano P; Biemans B; Benedetti M; Clayton AL Genes Brain Behav; 2018 Jan; 17(1):4-22. PubMed ID: 28753255 [TBL] [Abstract][Full Text] [Related]
19. Understanding the clinical manifestations of 16p11.2 deletion syndrome: a series of developmental case reports in children. Fetit R; Price DJ; Lawrie SM; Johnstone M Psychiatr Genet; 2020 Oct; 30(5):136-140. PubMed ID: 32732550 [TBL] [Abstract][Full Text] [Related]
20. Multiplex ligation-dependent probe amplification as a screening test in children with autism spectrum disorders. Łaczmańska I; Stembalska A; Złocińska M; Kozłowska J; Skiba P; Pesz K; Ślęzak R; Śmigiel R; Jakubiak A; Misiak B; Sąsiadek MM Adv Clin Exp Med; 2020 Jan; 29(1):101-106. PubMed ID: 31990460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]